CarthroniX Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$5.1M
- Investors
-
2
CarthroniX General Information
Description
Operator of a biopharmaceutical company designed to help in stem cell activation and tissue regeneration. The company utilizes molecular technology to advance therapies for degenerative and aging-related diseases, including arthritis, that help to preserve, repair, and regenerate cartilage in joints, suppress inflammation, heal wounds, regenerate skin, and prevent tissue fibrosis, enabling patients to enhance their physical activity and health.
Contact Information
Website
www.carthronix.comCorporate Office
- 43364 10th Street West
- Suite A
- Lancaster, CA 93534
- United States
Corporate Office
- 43364 10th Street West
- Suite A
- Lancaster, CA 93534
- United States
CarthroniX Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Grant | 01-Jan-2023 | $5.1M | Completed | Clinical Trials - Phase 1 | ||
| 2. Later Stage VC | 22-Apr-2022 | Completed | Clinical Trials - Phase 1 | |||
| 1. Seed Round | 12-Dec-2019 | $2.3M | $2.3M | Completed | Clinical Trials - Phase 1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
CarthroniX Comparisons
Industry
Financing
Details
CarthroniX Competitors (18)
One of CarthroniX’s 18 competitors is Orthotrophix, a Formerly VC-backed company based in Foster City, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Orthotrophix | Formerly VC-backed | Foster City, CA | ||||
| Qu Biologics | Private Equity-Backed | Burnaby, Canada | ||||
| Ampio Pharmaceuticals | Corporation | Englewood, CO | ||||
| Amplicore | Venture Capital-Backed | Mason, OH | ||||
| Xalud Therapeutics | Venture Capital-Backed | New York, NY |
CarthroniX Patents
CarthroniX Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4746877-A1 | Compositions and methods for modulating gp130 activity | Pending | 20-Jul-2023 | ||
| WO-2025019851-A1 | Compositions and methods for modulating gp130 activity | Inactive | 20-Jul-2023 | ||
| EP-4511378-A1 | Small molecule modulators of gp130 signaling pathways | Pending | 20-Apr-2022 | ||
| EP-4511378-A4 | Small molecule modulators of gp130 signaling pathways | Pending | 20-Apr-2022 | ||
| US-20250333423-A1 | Small molecule modulators of gp130 signaling pathways | Pending | 20-Apr-2022 | C07D513/04 |
CarthroniX Signals
CarthroniX Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| United States Department of War | Government | |||
| Pacira BioSciences | Corporation | Minority |
CarthroniX FAQs
-
When was CarthroniX founded?
CarthroniX was founded in 2015.
-
Where is CarthroniX headquartered?
CarthroniX is headquartered in Lancaster, CA.
-
What is the size of CarthroniX?
CarthroniX has 3 total employees.
-
What industry is CarthroniX in?
CarthroniX’s primary industry is Drug Discovery.
-
Is CarthroniX a private or public company?
CarthroniX is a Private company.
-
What is CarthroniX’s current revenue?
The current revenue for CarthroniX is .
-
How much funding has CarthroniX raised over time?
CarthroniX has raised $4.55M.
-
Who are CarthroniX’s investors?
United States Department of War and Pacira BioSciences have invested in CarthroniX.
-
Who are CarthroniX’s competitors?
Orthotrophix, Qu Biologics, Ampio Pharmaceuticals, Amplicore, and Xalud Therapeutics are some of the 18 competitors of CarthroniX.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process